DHRS7 and prostate carcinoma: Several studies have found that DHRS7 activity is reduced in prostate cancer patients (Araya et al., 2017); nonetheless, the expression of DHRS7 has been linked to cell proliferation and adhesion, suggesting that this molecule may operate as a tumor suppressor (Seibert et al., 2015).